Article | November 16, 2021

No Shortcuts: Two Pathways To Building A Future For Huntington's Disease Research

Source: Biorasi
iStock-1197955140 PS

One of the tenets of clinical research is that findings often result in more questions than answers, often leading to further solutions. For Huntington’s Disease, an inherited, neurodegenerative disorder identified in the 1800s, the journey towards understanding and treating this rare disease continues to be a methodical one. Dr. Ole Isacson highlights two pathways to ongoing research for this rare disease: building biomarkers and exploring gene therapy. Read about these pathways in the available article as well as potential detours that could delay or derail research momentum.

To learn more about Biorasi, visit their Clinical Leader page.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader